Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 13;12(7):e0179929.
doi: 10.1371/journal.pone.0179929. eCollection 2017.

Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction

Karim Stamboul  1   2   3 , Marianne Zeller  3 , Luc Rochette  3 , Yves Cottin  1   2   3 , Alexandre Cochet  2 , Thibault Leclercq  1 , Guillaume Porot  1 , Charles Guenancia  1   2   3 , Marie Fichot  1 , Nicolas Maillot  1 , Catherine Vergely  3 , Luc Lorgis  1   2   3
Affiliations

Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction

Karim Stamboul et al. PLoS One. .

Abstract

Main objective: To better understand the role of myeloperoxidases (MPO) in microvascular obstruction (MO) phenomenon and infarct size (IS) using cardiac magnetic resonance (CMR) data in patients with acute myocardial infarction (AMI).

Method: 40 consecutive patients classified according to the median level of MPO in the culprit artery. A CMR study was performed during the week following AMI and at 6 months, with late gadolinium enhancement sequences.

Results: Persistent MO was observed in the same proportion (50 vs. 65%, p = 0.728) between the low vs. high MPO group levels. However, the extent of the microvascular obstruction was significantly greater in the high-MPO group (6 (0-9) vs.16.5 (0-31), p = 0.027), together with a greater infarct size, and a trend towards a lower left ventricular ejection fraction (LVEF) (p = 0.054) at one week. CMR data at 6 months showed that reverse systolic remodeling was two fold more present in the low-MPO group (p = 0.058). Interestingly, the extent of MO (8.5 (6.5-31) vs. 4.1 (3-11.55), p = 0.042) and IS remained significantly greater (24.5 (9.75-35) vs. 7.5 (2.5-18.75), p = 0.022) in the high-MPO group. Moreover, MPO in the culprit artery appeared to correlate positively with MPO in non-culprit arteries and serum, and with troponin levels and peak CK.

Conclusion: This patient-based study revealed in patients after AMI that high MPO levels in the culprit artery were associated with more severe microvascular obstruction and greater IS. These findings may provide new insights pathophysiology explanation for the adverse prognostic impact of MO.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Infarct size regarding MPO plasma levels in the culprit artery assessed by CMR at day 3 and 6 months.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Yunoki K, Naruko T, Komatsu R, Shirai N, Nakagawa M, Sugioka K et al. Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction. Am J Cardiol 2010;105:922–929. doi: 10.1016/j.amjcard.2009.11.013 - DOI - PubMed
    1. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595–604. doi: 10.1056/NEJMoa035003 - DOI - PubMed
    1. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 2007;49:1993–2000. doi: 10.1016/j.jacc.2007.02.040 - DOI - PubMed
    1. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001;158:879–91. doi: 10.1016/S0002-9440(10)64036-9 - DOI - PMC - PubMed
    1. Funayama H, Ishikawa SE, Sugawara Y, Kubo N, Momomura S, Kawakami M. Myeloperoxidase may contribute to the no-reflow phenomenon in patients with acute myocardial infarction. Int J Cardiol 2010;139:187–92. doi: 10.1016/j.ijcard.2008.10.018 - DOI - PubMed